Global Heavy Ion Therapy Technology Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Heavy Ion Therapy Technology market size was valued at US$ 81.3 million in 2024 and is forecast to a readjusted size of USD 291 million by 2031 with a CAGR of 20.2% during review period.

One of the newer types of RT treatment uses protons or heavier ions. Unlike X-rays, protons (and heavier charged particles) deliver most of their dose in a well-defined Bragg peak. This allows more dose to be delivered to the tumour whilst sparing the healthy tissues, surrounding it. In particular, for protons, there is no exit dose beyond the target. For heavier charged particles, a fragmentation tail is observed and this is part of the reason why proton beam therapy (PBT) is considered preferable for treating childhood cancers, through reduced effects on growth, organ function and second malignancy risk later in life. Charged particle beams also offer the potential for treating tumours which lie close to critical organs, such as the brain or spinal cord. Heavier ions, such as carbon, have a substantially smaller (sharper) penumbra, potentially providing a significant advantage in this setting. In recent years, with the advancement of medical technology, the scale of the heavy particles therapy market has gradually expanded, which has driven the growth of demand for heavy particles therapy equipment in the market. This report focuses on the heavy particle therapy technology devices market.

In conventional heavy-particle radiotherapy equipment, only carbon ions are used. In multi-ion therapy, on the other hand, various kinds of ion beams—optimal for the specific malignancy—are combined to kill more cancer cells with fewer side effects. In 2022, QST and SHI succeeded in creating a multi-ion source, using neon, oxygen, and helium ions among others, making multi-ion radiotherapy possible. The system was installed at QST’s Heavy Ion Medical Accelerator in Chiba (HIMAC) for further research. With the new system, oxygen, heavier than carbon, was irradiated to the center of a tumor, and helium, lighter than carbon, was irradiated to an area nearer to normal tissue. Dose distribution and distribution of biological effects were also analyzed. Through a comparison with cases where only carbon ions were irradiated, it was confirmed that using different ion beams was more effective. In surgical treatments for sarcoma, depending on the site of the operation, patients often experience nerve injuries (neuropathy). Satisfactory results have been obtained using heavy ions, even for those patients for whom surgery would not have been possible. Moreover, in treatments of very large tumors, recurrence has been a frequent problem. The first case using multi-ion therapy occurred in November and December 2023, involving irradiation applied on the same patient 16 times. For the first time, carbon and oxygen irradiations were done on the same day, and switching between them was conducted smoothly. The patient was discharged the day after the treatments ended, and no early side effects were seen two months later.

This report is a detailed and comprehensive analysis for global Heavy Ion Therapy Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Heavy Ion Therapy Technology market size and forecasts, in consumption value ($ Million), 2020-2031

Global Heavy Ion Therapy Technology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Heavy Ion Therapy Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Heavy Ion Therapy Technology market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Heavy Ion Therapy Technology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Heavy Ion Therapy Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Toshiba, Hitachi, Lanzhou Ion Therapy Co., Ltd., CAS Ion Medical Technology Co., Ltd. (CASHIM), Sumitomo Heavy Industries (SHI), Siemens, Mevion, Varian Medical Systems, Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Heavy Ion Therapy Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Heavy Ion Therapy System

Protons Therapy System

Others

Market segment by Application

Hospital

Research Institute

Market segment by players, this report covers

Toshiba

Hitachi

Lanzhou Ion Therapy Co., Ltd.

CAS Ion Medical Technology Co., Ltd. (CASHIM)

Sumitomo Heavy Industries (SHI)

Siemens

Mevion

Varian Medical Systems, Inc

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Heavy Ion Therapy Technology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Heavy Ion Therapy Technology, with revenue, gross margin, and global market share of Heavy Ion Therapy Technology from 2020 to 2025.

Chapter 3, the Heavy Ion Therapy Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Heavy Ion Therapy Technology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Heavy Ion Therapy Technology.

Chapter 13, to describe Heavy Ion Therapy Technology research findings and conclusion.